Developed by Shray Alag, The Harker School
Sections: Correlations,
Clinical Trials, and HPO
Navigate: Clinical Trials and HPO
| Name (Synonyms) | Correlation |
|---|
Navigate: Correlations HPO
There is one clinical trial.
This is a pilot study to evaluate the feasibility of a COVID-19 virtual Post Intensive Care Syndrome (PICS) clinic (CoV-PICS). The findings from this study are the first steps in determining the feasibility and potential impact of a telehealth PICS clinic that is able to address the needs of patients with COVID-19 disease and potentially other patients that are unable to attend a brick and mortar clinic and require virtual care.
Description: Acceptability of Intervention Measure (AIM) Implementation of outcome measure. Response Scale: 1 = Completely disagree, 2 = Disagree, 3 = Neither agree nor disagree, 4 = Agree, 5 = Completely agree
Measure: Acceptance with virtual CoV-PICS Visits - AIM Time: up to 6 months after consentDescription: Intervention Appropriateness Measure (IAM) Implementation of outcome measure. Response Scale: 1 = Completely disagree, 2 = Disagree, 3 = Neither agree nor disagree, 4 = Agree, 5 = Completely agree
Measure: Acceptance with virtual CoV-PICS Visits - IAM Time: up to 6 months after consentDescription: Feasibility of Intervention Measure (FIM) Implementation of outcome measure. Response Scale: 1 = Completely disagree, 2 = Disagree, 3 = Neither agree nor disagree, 4 = Agree, 5 = Completely agree
Measure: Acceptance with virtual CoV-PICS Visits - FIM Time: up to 6 months after consentDescription: Katz Independence in Activities in Daily Living Rates daily activities by independence or dependence in completing the task (range 0-6) 0=low or patient very dependent, 6 = high or patient independent
Measure: PICS Symptoms - Daily living Time: Up to 6 months after consentDescription: Montreal Cognitive Assessment (MoCA) Screening tool for mild cognitive dysfunction. Sum all subscores listed on the right-hand side, for a possible maximum of 15 points. A final total score of 11 and above is considered normal.
Measure: PICS Systems - Cognitive Time: Up to 6 months after consentDescription: Scored Patient-Generated Subjective Global Assessment (PG-SGA) The Scored PG-SGA© includes the four patient-generated historical components (Weight History, Food Intake, Symptoms and Activities and Function - also known as the PG-SGA Short Form©), the professional part (Diagnosis, Age, Metabolic stress, and Physical Exam), the Global Assessment (A = well nourished, B = moderately malnourished or suspected malnutrition, C = severely malnourished), the total numerical score, and nutritional triage recommendations.
Measure: PICS Systems - Nutrition Time: Up to 6 months after consentDescription: Patient-Reported Outcomes Measurement Information System (PROMIS 29) PROMIS Profile instruments are a collection of short forms containing a fixed number of items from seven PROMIS domains (Depression, Anxiety, Physical Function, Pain Interference, Fatigue, Sleep Disturbance, and Ability to Participate in Social Roles and Activities). The PROMIS-29 assesses each of the 7 domains with 4 questions. Range 1=Never, 2=rarely, 3=sometimes, 4=often, 5=always
Measure: PICS Systems - PROMIS Time: Up to 6 months after consentDescription: ICU Memory Tool 4 item questionnaire of patient's memory of ICU stay. Response scale: factual memories (range 0-11), memories of feelings (range 0-6), delusional memories + 1 for mention of nurse or doctor trying to kill the patient in description (range 0-6)
Measure: PICS Symptoms - Memory Time: up to 6 months after consentAlphabetical listing of all HPO terms. Navigate: Correlations Clinical Trials
Data processed on September 26, 2020.
An HTML report was created for each of the unique drugs, MeSH, and HPO terms associated with COVID-19 clinical trials. Each report contains a list of either the drug, the MeSH terms, or the HPO terms. All of the terms in a category are displayed on the left-hand side of the report to enable easy navigation, and the reports contain a list of correlated drugs, MeSH, and HPO terms. Further, all reports contain the details of the clinical trials in which the term is referenced. Every clinical trial report shows the mapped HPO and MeSH terms, which are also hyperlinked. Related HPO terms, with their associated genes, protein mutations, and SNPs are also referenced in the report.
Drug Reports MeSH Reports HPO Reports